drugset
drugset / Trial / NCT07349758

Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers

NCT07349758 ↗

Phase 1 Recruiting 24 enrolled Johns Hopkins University National Institute on Drug Abuse (NIDA) · collab
NaSingle-groupOpen-labelOther

Summary

The goal of this study is to evaluate the pharmacokinetics of a one-time dosing of two F/TAF tablets over a 14-day period.

Timeline

Start
2026-01-06
Primary completion
2027-01-01
Completion
2028-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject emtricitabine Other / unclassified 400 mg Oral
Subject tenofovir alafenamide Small molecule 50 mg Oral

Indications

No indication recorded.